Pura Vida Investments, LLC Novavax Inc Call Options Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 15, 2020	SELL	$3.93 - $16.0 $1.29 Million - $5.24 Million	-327,800 Closed	0 $0
Q4 2019 Feb 12, 2021	BUY	$3.69 - $5.22 $1.2 Million - $1.69 Million	324,522 Added 9900.0%	327,800 $1.31 Million
Q4 2019 Feb 14, 2020	SELL	$3.69 - $5.22 $1.2 Million - $1.69 Million	-324,522 Reduced 99.0%	3,278 $9,000
Q3 2019 Feb 12, 2021	BUY	$4.02 - $7.84 $1.3 Million - $2.54 Million	324,522 Added 9900.0%	327,800 $1.65 Million
Q3 2019 Nov 14, 2019	SELL	$4.02 - $7.84 $1.3 Million - $2.54 Million	-324,522 Reduced 99.0%	3,278 $9,000
Q2 2019 Feb 12, 2021	BUY	$4.93 - $12.2 $1.6 Million - $3.96 Million	324,522 Added 9900.0%	327,800 $1.92 Million
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $16,160 - $39,991	3,278 New	3,278 $9,000

284

83.2M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $1.04B
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.